Source: World Intellectual Property Organization (WIPO) Handbook on Industrial Property Information and Documentation, Standard ST.25: Standard for the Presentation of Nucleotide and Amino Acid Sequence Listings in Patent Applications (2009).
Symbol
| Meaning
|
---|
ac4c | 4-acetylcytidine.
|
chm5u | 5-(carboxyhydroxymethyl)uridine.
|
cm | 2′-O-methylcytidine.
|
cmnm5s2u | 5-carboxymethylaminomethyl-2-thiouridine.
|
cmnm5u | 5-carboxymethylaminomethyluridine.
|
d | dihydrouridine.
|
fm | 2′-O-methylpseudouridine.
|
gal q | beta, D-galactosylqueuosine.
|
gm | 2′-O-methylguanosine.
|
i | inosine.
|
i6a | N6-isopentenyladenosine.
|
m1a | 1-methyladenosine.
|
m1f | 1-methylpseudouridine.
|
m1g | 1-methylguanosine.
|
m1i | 1-methylinosine.
|
m22g | 2,2-dimethylguanosine.
|
m2a | 2-methyladenosine.
|
m2g | 2-methylguanosine.
|
m3c | 3-methylcytidine.
|
m5c | 5-methylcytidine.
|
m6a | N6-methyladenosine.
|
m7g | 7-methylguanosine.
|
mam5u | 5-methylaminomethyluridine.
|
mam5s2u | 5-methoxyaminomethyl-2-thiouridine.
|
man q | beta, D-mannosylqueuosine.
|
mcm5s2u | 5-methoxycarbonylmethyl-2-thiouridine.
|
mcm5u | 5-methoxycarbonylmethyluridine.
|
mo5u | 5-methoxyuridine.
|
ms2i6a | 2-methylthio-N6-isopentenyladenosine.
|
ms2t6a | N-((9-beta-D-ribofuranosyl-2-methylthiopurine-6-yl)carbamoyl)threonine.
|
mt6a | N-((9-beta-D-ribofuranosylpurine-6-yl)N-methylcarbamoyl)threonine.
|
mv | uridine-5-oxyacetic acid-methylester.
|
o5u | uridine-5-oxyacetic acid.
|
osyw | wybutoxosine.
|
p | pseudouridine.
|
q | queuosine.
|
s2c | 2-thiocytidine.
|
s2t | 5-methyl-2-thiouridine.
|
s2u | 2-thiouridine.
|
s4u | 4-thiouridine.
|
t | 5-methyluridine.
|
t6a | N-((9-beta-D-ribofuranosylpurine-6-yl)-carbamoyl)threonine.
|
tm | 2′-O-methyl-5-methyluridine.
|
um | 2′-O-methyluridine.
|
yw | wybutosine.
|
x | 3-(3-amino-3-carboxy-propyl)uridine, (acp3)u. |
[86 FR 57052, Oct. 14, 2021]
source: 24 FR 10332, Dec. 22, 1959, unless otherwise noted.